Related Experiment Videos
Pregnancy after uterine arterial embolization.
Cláudio E Bonduki1, Paulo C Feldner, Juliana da Silva
1Department of Gynecology, Federal University of São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo, Brazil)
|July 27, 2011
Summary
Pregnancy after uterine artery embolization (UAE) for fibroids is possible, with most resulting in live births. However, there is an increased risk of Cesarean delivery.
Area of Science:
- Reproductive Medicine
- Interventional Radiology
- Obstetrics & Gynecology
Background:
- Uterine artery embolization (UAE) is a common treatment for symptomatic uterine fibroids.
- Data on pregnancy outcomes following UAE is limited.
- Understanding risks and outcomes is crucial for patient counseling.
Purpose of the Study:
- To evaluate pregnancy outcomes, complications, and neonatal outcomes in women who previously underwent UAE.
- To assess the safety and feasibility of pregnancy after UAE.
Main Methods:
- Retrospective study of 187 women treated with UAE for uterine fibroids (2005-2008).
- UAE performed using polyvinyl alcohol particles (500-900 mm).
- Pregnancies identified via questionnaires and study database.
Main Results:
- 15 spontaneous pregnancies occurred, with a live birth rate of 87.5%.
- Mean time to conception was 23.8 months post-UAE.
- Complications included two cases of placenta accreta (12.5%) and all deliveries were Cesarean sections.
Conclusions:
- Pregnancy following UAE is achievable with a high live birth rate.
- While Cesarean delivery is more common, other major obstetric risks appear minimal.
- UAE may be a viable option for women desiring future fertility.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...